NL-OMON56403尚未招募不适用
In vitro quality assessment of myogenic stem cells in multiple patient groups with confirmed skeletal muscle atrophy to study their potential for autologous stem cell therapy - ATROMAB
Medisch Universitair Ziekenhuis Maastricht0 个研究点目标入组 80 人开始时间: 待定最近更新:
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 发起方
- 入组人数
- 80
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •Patient group: cachexia - Diagnosed with non-small cell lung cancer (NSCLC),
- •stage 3-4 - Diagnosed with cachexia (>5% unintentional body weight loss in past
- •six months) - Age 50-60 and 60-70 - Written informed consent Patient group:
- •muscle impaired elderly - Scheduled for knee-, back- or hip surgery - Age 60-70
- •and 70-80y - Written informed consent Controls - Scheduled for knee-, back- or
- •hip surgery - Age 50-60, 60-70 and 70-80 - Written informed consent
排除标准
- •- No informed consent
- •- Suffering from a muscular dystrophy or other disease known to affect muscle
- •morphology or function
- •- Have a weekly alcohol intake of >= 35 units (men) or >= 24 units (women)
- •- Ongoing participation in other intervention clinical trials
- •- Major surgery within 4 weeks of the visit
- •- Patients unable and/or unwilling to comply with treatment and study
- •instructions
- •- Any other factor that in the opinion of the investigator excludes the patient
- •from the study
研究者
相似试验
终止
不适用
Muscle Stem Cell Quality in AtrophyMuscle WeaknessAtrophy, MuscleCachexiaSarcopeniaStem Cell TransplantationMesenchymal Stem CellsNCT06077734Maastricht University Medical Center7
已完成
2 期
Treatment of stress urinary incontinence in womeStress Urinary Incontinences in women.Stress incontinence (female) (male)N39.3IRCT20140911019125N7Kerman University of Medical Sciences25
招募中
1 期
Evaluation the efficacy of stem cells condition medium on hair transplantation outcomeHair loss.Nonscarring hair loss, unspecifiedL65.9IRCT20200127046282N18Skin and Stem cell Research Center of Tehran University of Medical Sciences30
招募中
不适用
Extraction and evaluation of mesenchymal stem cells from bone marrow aspirate.JPRN-UMIN000048061Keio University50
进行中（未招募）
1 期
Mesenchymal Stem Cell Therapy for SARS-CoV-2-related Acute Respiratory Distress SyndromeModerate to severe SARS-Cov-2 related acute respiratory distress syndromeMedDRA version: 23.0Level: PTClassification code 10084268Term: COVID-19System Organ Class: 10021881 - Infections and infestationsEUCTR2020-002772-12-FRCHRU NANCY30